These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15827106)

  • 1. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.
    San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
    Draper N; Powell BL; Franks S; Conway GS; Stewart PM; McCarthy MI
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):64-70. PubMed ID: 16817821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.
    Martínez-García MA; San-Millán JL; Escobar-Morreale HF
    Gene; 2012 Apr; 497(1):38-44. PubMed ID: 22306327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.
    White PC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5880-3. PubMed ID: 16091483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia.
    Smit P; Dekker MJ; de Jong FJ; van den Beld AW; Koper JW; Pols HA; Brinkmann AO; de Jong FH; Breteler MM; Lamberts SW
    J Clin Endocrinol Metab; 2007 Jan; 92(1):359-62. PubMed ID: 17062770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
    Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
    Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population.
    Ju R; Wu W; Tang Q; Wu D; Xia Y; Wu J; Wang X
    PLoS One; 2015; 10(10):e0140326. PubMed ID: 26452272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic syndrome and type 2 diabetes.
    Moon SS; Lee YS; Kim JG; Kim SW; Jeong JY; Jeon EJ; Seo HA; Kwak SH; Park KS; Lee IK
    Endocr J; 2011; 58(11):949-59. PubMed ID: 21869537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome.
    Qin K; Rosenfield RL
    Steroids; 2011 Jan; 76(1-2):135-9. PubMed ID: 21050867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.
    Gambineri A; Fanelli F; Tomassoni F; Munarini A; Pagotto U; Andrew R; Walker BR; Pasquali R
    Eur J Endocrinol; 2014 Jul; 171(1):47-57. PubMed ID: 24743397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H6PD Gene Polymorphisms (R453Q and D151A) and Polycystic Ovary Syndrome: A Case-Control Study in A Population of Iranian Kurdish Women.
    Naseri R; Alimoradi Y; Sohrabi M; Cheraghian Fard M; Barzingarosi E; Abdolmaleki A; Jalili C
    Int J Fertil Steril; 2022 Aug; 16(3):180-183. PubMed ID: 36029054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
    Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
    Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.
    Valkenburg O; Uitterlinden AG; Themmen AP; de Jong FH; Hofman A; Fauser BC; Laven JS
    Hum Reprod; 2011 Oct; 26(10):2902-11. PubMed ID: 21803757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells.
    Senesi S; Marcolongo P; Manini I; Fulceri R; Sorrentino V; Csala M; Bánhegyi G; Benedetti A
    J Mol Endocrinol; 2008 Sep; 41(3):125-33. PubMed ID: 18586838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
    Gambineri A; Tomassoni F; Munarini A; Stimson RH; Mioni R; Pagotto U; Chapman KE; Andrew R; Mantovani V; Pasquali R; Walker BR
    Eur J Endocrinol; 2011 Aug; 165(2):283-92. PubMed ID: 21622477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.